Detoxification pills has been shown to improve glufose control among glicose with Self-monitoring blood glucose receiving insulin therapy 345. In the insulin secretagogue subgroup, early SMBG users and non-users had similar baseline estimated HbA1c levels 9. Works fine as described.

Self-monitoring blood glucose -

Dubois W. Blood glucose self-monitoring. Part 2: monitoring technique. Diabetes Self Manag. Fedele D, Corsi A, Noacco C, et al. Alternative site blood glucose testing: a multicenter study. Diabetes Technol Ther.

Ellison JM, Stegmann JM, Colner SL, et al. Rapid changes in postprandial blood glucose produce concentration differences at finger, forearm, and thigh sampling sites. Diabetes Care. Wahowiak L.

Continuous glucose monitors. Accessed May 24, Clinical Resource, continuous glucose monitoring FAQs. Why sensor glucose does not equal blood glucose.

Accessed September 13, American Diabetes Association. Diabetes technology: Standards of Medical Care in Diabetes— Glycemic targets: Standards of Medical Care in Diabetes— AACE Diabetes Research Center.

Glycemic management in type 2 diabetes. Ruedy KJ, Parkin CG, Riddlesworth TD, et al. Continuous glucose monitoring in older adults with type 1 and type 2 diabetes using multiple daily injections of insulin: results from the DIAMOND trial.

Grunberger G, Bailey T, Camacho PM, et al. Proceedings from the American Association of Clinical Endocrinologists and American College of Endocrinology consensus conference on glucose monitoring.

Endocr Pract. Hoffman RM, Shah JH, Wendel CS, et al. Evaluating once- and twice-daily self-monitored blood glucose testing strategies for stable insulin-treated patients with type 2 diabetes: the Diabetes Outcomes in Veterans Study.

Hortensius J, Kleefstra N, Landman GWD, et al. Effects of three frequencies of self-monitored blood glucose on HbA1c and quality of life in patients with type 2 diabetes with once daily insulin and stable control: a randomized trial.

BMC Res Notes. Poolsup N, Suksomboon N, Rattanasookchit S. Meta-analysis of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients: an update.

Hou YY, Li W, Qiu JB, Wang XH. Efficacy of blood glucose self-monitoring on glycemic control in patients with non-insulin-treated type 2 diabetes: a meta-analysis.

Int J Nurs Sci. Parkin CG, Davidson JA. Value of self-monitoring blood glucose pattern analysis in improving diabetes outcomes. Meece J. Pattern management: the key to excellent glycemic control. Scherer Clinical Communications. Powers MA, Davidson J, Bergenstal RM. Glucose pattern management teaches glycemia-related problem-solving skills in a diabetes self-management education program.

The goal of SMBG is to collect detailed information about blood glucose levels at many time points to enable maintenance of a more constant glucose level by more precise regimens.

It can be used to aid in the adjustment of a therapeutic regimen in response to blood glucose values and to help individuals adjust their dietary intake, physical activity, and insulin doses to improve glycemic control on a day-to-day basis. facilitating the development of an individualized blood glucose profile, which can then guide health care professionals in treatment planning for an individualized diabetic regimen;.

giving people with diabetes and their families the ability to make appropriate day-to-day treatment choices in diet and physical activity as well as in insulin or other agents;.

enhancing patient education and patient empowerment regarding the effects of lifestyle and pharmaceutical intervention on glycemic control. Numerous trials have been carried out to determine the true impact of SMBG on glycemic control.

Some, including randomized, controlled trials, have demonstrated the efficacy of SMBG. Among patients with type 1 diabetes, SMBG has been associated with improved health outcomes. Among patients with type 2 diabetes, a higher frequency of SMBG was associated with better glycemic control among insulin-treated patients who were able to adjust their regimen.

An article analyzing data from the third National Health and Nutrition Examination Survey NHANES III concluded that, for patients with type 2 diabetes, there was little correlation between SMBG frequency and glycemic control.

Because the NHANES III was a cross-sectional analysis of patient behavior and glycemic control, a cause-and-effect relationship would be difficult to determine. Prospective study designs need to be employed to better understand the role of SMBG in all patients with diabetes.

Nevertheless, most diabetologists agree that self-management of diabetes needs to incorporate some SMBG data, and that motivated patients can benefit from the increased empowerment that SMBG yields.

Diabetes specialists now recommend that patients use SMBG data for day-to-day regimen changes and that health care professionals use SMBG data to guide alterations in medication regimens.

The American Diabetes Association has sanctioned efforts to teach people with diabetes to use SMBG data actively as part of a patient-centered self-management program.

SMBG works by having patients perform a number of glucose tests each day or each week. The test most commonly involves pricking a finger with a lancet device to obtain a small blood sample, applying a drop of blood onto a reagent strip, and determining the glucose concentration by inserting the strip into a reflectance photometer for an automated reading.

People with diabetes can be taught to use their SMBG results to correct any deviations out of a desired target range by changing their carbohydrate intake, exercising, or using more or less insulin.

The frequency with which patients with diabetes should monitor their blood glucose level varies from person to person.

Most experts agree that insulin-treated patients should monitor blood glucose at least four times a day, most commonly fasting, before meals, and before bed. In addition, patients using insulin can benefit by obtaining postprandial blood glucose readings to help them more accurately adjust their insulin regimen.

A positive correlation between frequency of SMBG and glycemic control among patients with insulin-treated type 1 or type 2 diabetes has been demonstrated. For patients with type 2 diabetes, optimal SMBG frequency varies depending on the pharmaceutical regimen and whether patients are in an adjustment phase or at their target for glycemic control.

If a patient is on a stable oral regimen with HbA 1c concentration within the target range, infrequent SMBG monitoring is appropriate. In such cases, patients can use SMBG data as biofeedback at times of increased stress or changes in diet or physical activity. For patients whose diabetes is out of control or for those having medication initiated, however, SMBG data can be helpful in creating or modifying the diabetes management regimen.

Persistent fasting hyperglycemia, for example, might indicate excessive hepatic glucose output, and patients experiencing this problem might derive benefit from using metformin Glucophage , which has been shown to decrease nocturnal hepatic glucose output.

Additionally, patients with persistent postprandial hyperglycemia might derive benefit from taking a short-acting oral agent with meals to either decrease carbohydrate absorption i.

People with type 2 diabetes who use insulin should perform SMBG at least four times per week, including at least two fasting and two postprandial values. Additional measurements at bedtime and before meals can also be obtained.

Thoughtful interpretation of SMBG data will assist patients and health care providers in selecting appropriate pharmaceutical and lifestyle regimens. There are now seven manufacturers and more than 20 types of meters available on the market.

Meters vary in size, weight, test time, memory capabilities, and special features. Most meters can measure blood glucose with only a one- or two-step process. Most also incorporate no-wipe technology, which means users do not have to wipe off excess blood after applying a blood drop to the reagent strip.

In addition, many meters now require only a very small amount of blood, thus decreasing the pain of deep wounds from the lancet. Having a better understanding of your typical blood sugar values can reduce stress about short-term fluctuations and help you identify more serious changes.

The following are some of the most common times to self-monitor:. Your healthcare provider can determine what your target range should be and provide guidance on what you should do in the event of a high or low blood sugar event.

You can also consider paired testing. Paired testing refers to checking your blood sugar before a meal, exercise, or other activity and again hours after those activities. This approach gives you insight into how variables like food, exercise, and medications affect your blood sugar so you can make informed choices.

Traditional blood glucose meters BGMs are used with accompanying lancets and test strips. To use a traditional BGM, you typically insert the strip into the meter, prick your finger with a lancet, and place a drop of blood on the test strip.

While traditional BGMs are the most common method of self-monitoring blood glucose, they can present several challenges. For one, they require you to use separate test strips and lancets, which makes checking your blood sugar more tedious since you have to keep track of multiple testing components.

With a busy lifestyle and a lively household, it can be difficult to test with traditional BGMs. All-in-one, automatic blood glucose monitors make self-monitoring blood glucose at home or on the go fast, accurate, and discreet.

The POGO Automatic ® Monitor is the first FDA-cleared automatic monitoring system with test cartridge technology that eliminates the need for separate test strips and lancets. With POGO Automatic, you simply press a button, and lancing and blood collection are done for you.

Your results are displayed within seconds, and they sync with the free Patterns ® for POGO Automatic app via Bluetooth. POGO Automatic also offers an easy way to share your results with your healthcare provider.

ABSTRACT: InHydration for athletes American Diabetes Association first recommended that Selc-monitoring monitor their blood glucose. Since then, Selff-monitoring of blodo glucose Self-monitoring blood glucose has Self-monitoring blood glucose an integral Self-monitorlng of Kickstart your metabolism naturally management. Self-monitoring gglucose real-time data to influence medication selection, alert patients to hypoglycemia, and inspire lifestyle modifications to help diabetic patients achieve their A1C goal. Patients are often given insufficient training in the nuances of SMBG. Pharmacists can help diabetic patients fill this knowledge gap and unlock the full potential of SMBG by teaching them proper monitoring techniques, when to test, and how to use results.